A Randomized, Double-blind Study to Evaluate the Efficacy of Ammonium Lactate Lotion 12% (Lac-hydrin) and Halobetasol Propionate Ointment 0.05% (Ultravate) in the Treatment and Maintenance of Psoriasis.
Phase of Trial: Phase IV
Latest Information Update: 30 Jun 2016
At a glance
- Drugs Ammonium lactate (Primary) ; Ulobetasol (Primary)
- Indications Plaque psoriasis
- Focus Therapeutic Use
- 08 Feb 2011 Results presented at the 69th Annual Meeting of the American Academy of Dermatology.
- 03 May 2010 New trial record